StrideBio, Inc. [RESEARCH TRIANGLE PARK, NC] announced the appointment of Mark Velleca as Chief Executive Officer. Velleca succeeds Sapan Shah who is leaving StrideBio to pursue other opportunities after having served as Chief Executive Officer for the past three years. Velleca joins StrideBio from Hatteras Venture Partners where he is a Venture Partner.
StrideBio is a North Carolina-based biotechnology firm that develops and commercializes gene therapies for the treatment of CNS and cardiovascular disorders.